🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

South African doctor says patients with Omicron variant have "very mild" symptoms

Published 11/28/2021, 11:14 AM
Updated 11/28/2021, 04:01 PM
© Reuters. FILE PHOTO: A passenger in a taxi wears a face mask with colours of the South African flag after the announcement of a British ban on flights from South Africa because of the detection of a new coronavirus disease (COVID-19) variant, in Soweto, South Afri

By Promit Mukherjee

JOHANNESBURG (Reuters) - A South African doctor who was one of the first to suspect a different coronavirus strain among patients said on Sunday that symptoms of the Omicron variant were so far mild and could be treated at home.

Dr. Angelique Coetzee, a private practitioner and chair of South African Medical Association, told Reuters that on Nov. 18 she noticed seven patients at her clinic who had symptoms different from the dominant Delta variant, albeit "very mild".

Now designated Omicron by the World Health Organization, the variant was detected and announced by South Africa's National Institute of Communicable Diseases (NICD) on Nov. 25 from samples taken from a laboratory from Nov. 14 to Nov. 16.

Coetzee said a patient on Nov. 18 reported at her clinic being "extremely fatigued" for two days with body aches and headache.

"Symptoms at that stage was very much related to normal viral infection. And because we haven't seen COVID-19 for the past eight to 10 weeks, we decided to test," she said, adding that the patient and his family turned out to be positive.

On the same day, more patients came in with similar symptoms, which was when she realised there was "something else going on." Since then, she's seen two to three patients a day.

"We have seen a lot of Delta patients during the third wave. And this doesn't fit in the clinical picture," she said, adding she alerted NICD on the same day with the clinical results.

"Most of them are seeing very, very mild symptoms and none of them so far have admitted patients to surgeries. We have been able to treat these patients conservatively at home," she said.

Coetzee, who is also on the Ministerial Advisory Committee on Vaccines, said unlike the Delta so far patients have not reported loss of smell or taste and there has been no major drop in oxygen levels with the new variant.

Her experience so far has been that the variant is affecting people who are 40 or younger. Almost half of the patients with Omicron symptoms that she treated were not vaccinated.

"The most predominant clinical complaint is severe fatigue for one or two days. With them, the headache and the body aches and pain."

© Reuters. International check-in counters stand empty as several airlines stopped flying out of South Africa, amidst the spread of the new SARS-CoV-2 variant Omicron, at O.R. Tambo International Airport in Johannesburg, South Africa, November 28, 2021. REUTERS/ Sumaya Hisham

The news of the new variant emerging from South Africa prompted a swift reaction from several countries, including Britain, which on Friday imposed a travel ban on several southern African countries with immediate effect, a decision South Africa has strongly contested.

Since Friday, many countries have also banned air travel to and from South Africa, including the United States, other European countries, and some Asian nations.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.